pharmaceutical chemistry

Summary

Alias: pharmaceutic chemistry
Summary: Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use.

Webpages

  1. icbg central asia
    icbg.rutgers.edu/links.htm
  2. slavica eric
    pharmacy.bg.ac.yu/farm_hem/eric.htm
  3. ryszard stolarski
    www.biogeo.uw.edu.pl/people/stolarsk_en.html
  4. zyban (bupropion
    www.chm.bris.ac.uk/motm/zyban/zyban.htm
  5. pharmaceutics newsletters | 2000
    www.pharmacy.utah.edu/pharmaceutics/news/2000.html
  6. ruconnected: pharmacy electives
    ruconnected.ru.ac.za/course/category.php?id=53
  7. dr. david c. perry
    www.gwumc.edu/pharm/DCPerryhomepage.html
  8. facilities - department of pharmaceutical chemistry
    www.hbc.ku.edu/phch/facilite.htm
  9. ucsf helen diller family comprehensive cancer center - people - paul r. ortiz de montellano, phd
    cancer.ucsf.edu/people/ortiz-de-montellano_paul.php
  10. ruconnected: pharmacy
    ruconnected.ru.ac.za/course/category.php?id=8

Research Grants

  1. Methods & Noninvasive PK Study to Improve Iontophoresis
    S Kevin Li; Fiscal Year: 2007
  2. Methods & Noninvasive PK Study to Improve Iontophoresis
    S Kevin Li; Fiscal Year: 2008
  3. Methods & Noninvasive PK Study to Improve Iontophoresis
    S Kevin Li; Fiscal Year: 2005
  4. Pharmaceutical Aspects of Biotechnology Training
    CHARLES R MIDDAUGH; Fiscal Year: 2006
  5. EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION
    GLADYS ESCALONA DE MOTTA; Fiscal Year: 2002
  6. Acquistion of a 600MHz NMR Spectrometer
    Arlene D Albert; Fiscal Year: 2003
  7. 16th Internat'l Symposium: Radiopharmaceutical Chemistry
    TIM JOHN TEWSON; Fiscal Year: 2005
  8. Development of Catalysts for C=C and C-N Bond Forming Reactions
    Ian C Stewart; Fiscal Year: 2008
  9. Small Molecule Inhibitors of C. perfringens Epsilon-Toxin
    Vladimir A Karginov; Fiscal Year: 2008
  10. Stereoselectivities of Synthetic Organic Reactions
    Kendall N Houk; Fiscal Year: 2006

Publications

  1. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC
    Jolly M Sankalia
    Centre of Relevance and Excellence in Novel Drug Delivery Systems, Pharmacy Department, The M S University of Baroda, G H Patel building, Donor s Plaza, Vadodara, Gujarat 390002, India
    J Control Release 129:49-58
  2. Release profile comparison and stability of diltiazem-resin microcapsules in sustained release suspensions
    Varaporn Buraphacheep Junyaprasert
    Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 447 Sri Ayutthaya Road, Bangkok 10400, Thailand
    Int J Pharm 352:81-91
  3. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation
    T Nabais
    Faculty of Pharmacy, University of Montreal, Montreal, Que, Canada
    Eur J Pharm Biopharm 65:371-8
  4. Formulation of controlled-release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation
    Hamdy Abdelkader
    Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, Egypt
    AAPS PharmSciTech 8:E100
  5. Floating osmotic drug delivery system of ranitidine hydrochloride: development and evaluation--a technical note
    Pramod Kumar
    Department of Pharmaceutics, Institute of Technology, Banaras Hindu University, Varanasi 221005, U.P, India
    AAPS PharmSciTech 9:480-5
  6. Design and study of lamivudine oral controlled release tablets
    Punna Rao Ravi
    Pharmacy Group, Faculty Division III, Birla Institute of Technology and Science, Pilani, Rajasthan, India
    AAPS PharmSciTech 8:E101
  7. Sustained-release tablets of indomethacin-loaded microcapsules: preparation, in vitro and in vivo characterization
    Bin Lu
    West China School of Pharmacy, Sichuan University, Chengdu 610041, China
    Int J Pharm 333:87-94
  8. Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets
    Eddy Castellanos Gil
    Center of Pharmaceutical Chemistry, Calle 200, esq 21, Atabey, Playa, Havana, Cuba
    AAPS PharmSciTech 8:E115
  9. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone
    Ian J Hardy
    Pharmaceutical Research and Development, Merck Sharp and Dohme Ltd, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom
    Int J Pharm 337:246-53
  10. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets
    Antonia Miranda
    Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain
    J Pharm Sci 96:2746-56

Scientific Experts

Detail Information

Webpages102 found, 30 most recent shown here

  1. icbg central asia
    icbg.rutgers.edu/links.htm
  2. slavica eric
    pharmacy.bg.ac.yu/farm_hem/eric.htm
  3. ryszard stolarski
    www.biogeo.uw.edu.pl/people/stolarsk_en.html
  4. zyban (bupropion
    www.chm.bris.ac.uk/motm/zyban/zyban.htm
  5. pharmaceutics newsletters | 2000
    www.pharmacy.utah.edu/pharmaceutics/news/2000.html
  6. ruconnected: pharmacy electives
    ruconnected.ru.ac.za/course/category.php?id=53
  7. dr. david c. perry
    www.gwumc.edu/pharm/DCPerryhomepage.html
  8. facilities - department of pharmaceutical chemistry
    www.hbc.ku.edu/phch/facilite.htm
  9. ucsf helen diller family comprehensive cancer center - people - paul r. ortiz de montellano, phd
    cancer.ucsf.edu/people/ortiz-de-montellano_paul.php
  10. ruconnected: pharmacy
    ruconnected.ru.ac.za/course/category.php?id=8
  11. faculty of pharmaceutical sciences, teikyo university
    www.pharm.teikyo-u.ac.jp/lab/yakka/index_e.html
  12. dr john m sanderson - pharmaceutical chemistry
    www.dur.ac.uk/j.m.sanderson/science/lectures/PC/PC.html
  13. guidelines from the danish medicines agency on its expectations of a qualified person in a pharmaceutical company
    www.dkma.dk/1024/visUKLSArtikel.asp?artikelID=14732
  14. cip members - alastair aitken
    www.cip.ed.ac.uk/members/not_HRB/aitken/index.htm
  15. pharmacy courses-amrita institute of medical sciences
    www.aimshospital.org/academics/pharmacy-college/pharmacy-cou ...
  16. memórias do instituto oswaldo cruz - vol.100(4) july 2005
    memorias.ioc.fiocruz.br/100(4)/5309.html
  17. center for nanotechnology: research: faculty research
    www.nano.washington.edu/research/faculty.asp?id=85
  18. uw school of pharmacy - news & events
    depts.washington.edu/pha/news-events/news-outstandingdean.ht ...
  19. james t. dalton, phd
    www.pharmacy.ohio-state.edu/programs/ceut/faculty/dalton/
  20. professor basil roufogalis - the university of sydney
    www.cancerresearch.med.usyd.edu.au/members/profiles/broufoga ...
  21. school of pharmacy - university of athens
    www.pharm.uoa.gr/eng/sitemap.htm
  22. chemistry | uw-whitewater
    www.uww.edu/academics/majors/factsheets/chemistry.php
  23. pharmaceutical chemistry
    www.hbc.ku.edu/phch/facilities.htm
  24. research: dr lucia sivilotti
    ucl.ac.uk/Pharmacology/Research/ls.html
  25. electron j biomed 2005;1:40-45 arellano et al. high-level aminoglycoside resistance enterococcus spp
    biomed.uninet.edu/2005/n1/arellano.html
  26. boranes in organic chemistry
    eurasianchemtech.vub.ac.be/contents/03_5_2_83.html
  27. department of pharmacology, obafemi awolowo university
    www.oauife.edu.ng/faculties/pharmacy/pharmacology.htm
  28. no title
    www.dsfarm.unipd.it/research2002/palumbo/palumbo.en.htm
  29. nih news release--researchers discover how embryo attaches to the uterus--01/16/2003
    www.nih.gov/news/pr/jan2003/nichd-16.htm
  30. dr john m sanderson - publicatons
    www.dur.ac.uk/j.m.sanderson/science/./pub.html
  31. pharmaceutics newsletters | 2004
    www.pharmacy.utah.edu/pharmaceutics/news/2004.html

Research Grants11

  1. Methods & Noninvasive PK Study to Improve Iontophoresis
    S Kevin Li; Fiscal Year: 2007
    ..The project will be led by scientists in pharmaceutics and pharmaceutical chemistry (S.K. Li, College of Pharmacy, University of Utah), physics and radiology (E-K...
  2. Methods & Noninvasive PK Study to Improve Iontophoresis
    S Kevin Li; Fiscal Year: 2008
    ..The project will be led by scientists in pharmaceutics and pharmaceutical chemistry (S.K. Li, College of Pharmacy, University of Utah), physics and radiology (E-K...
  3. Methods & Noninvasive PK Study to Improve Iontophoresis
    S Kevin Li; Fiscal Year: 2005
    ..The project will be led by scientists in pharmaceutics and pharmaceutical chemistry (S.K. Li, College of Pharmacy, University of Utah), physics and radiology (E-K...
  4. Pharmaceutical Aspects of Biotechnology Training
    CHARLES R MIDDAUGH; Fiscal Year: 2006
    ..For the past 30 years the Department of Pharmaceutical Chemistry at the University of Kansas has had an internationally recognized program for training pharmaceutical ..
  5. EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION
    GLADYS ESCALONA DE MOTTA; Fiscal Year: 2002
    ..ft. Molecular Sciences Complex. The funds to house faculty members in Neuroscience, Protein Studies, and Pharmaceutical Chemistry will significantly contribute to CNS achieving the following objectives: 1) increase the number of women ..
  6. Acquistion of a 600MHz NMR Spectrometer
    Arlene D Albert; Fiscal Year: 2003
    ..The instrument will mainly serve the Departments of Molecular and Cell Biology, Chemistry and Pharmaceutical Chemistry at the University of Connecticut - Storrs campus...
  7. 16th Internat'l Symposium: Radiopharmaceutical Chemistry
    TIM JOHN TEWSON; Fiscal Year: 2005
    ..to provide support for students and post-docs to attend the 16th International Symposium on Radio-pharmaceutical Chemistry which will be held at the University of Iowa, Iowa City, Iowa on June 24 -28, 2005...
  8. Development of Catalysts for C=C and C-N Bond Forming Reactions
    Ian C Stewart; Fiscal Year: 2008
    ..Since the asymmetric synthesis of nitrogen-containing products plays an important role in medicinal and pharmaceutical chemistry, this contribution will ultimately facilitate the discovery of compounds for the treatment of human ..
  9. Small Molecule Inhibitors of C. perfringens Epsilon-Toxin
    Vladimir A Karginov; Fiscal Year: 2008
    ..perfringens epsilon-toxin. (2) Utilize initial testing data in concert with pharmaceutical chemistry to design and synthesize a biased library of beta- cyclodextrin derivatives with an enhanced affinity to ..
  10. Stereoselectivities of Synthetic Organic Reactions
    Kendall N Houk; Fiscal Year: 2006
    ..from synthetic groups, and these people have become leaders in computational understanding of organic and pharmaceutical chemistry. The specific aims for the new grant period are: Aim 1: Development of quantum mechanical methods to ..
  11. Stereoselectivities of Synthetic Organic Reactions
    Kendall N Houk; Fiscal Year: 2008
    ..from synthetic groups, and these people have become leaders in computational understanding of organic and pharmaceutical chemistry. The specific aims for the new grant period are: Aim 1: Development of quantum mechanical methods to ..

Publications62

  1. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC
    Jolly M Sankalia
    Centre of Relevance and Excellence in Novel Drug Delivery Systems, Pharmacy Department, The M S University of Baroda, G H Patel building, Donor s Plaza, Vadodara, Gujarat 390002, India
    J Control Release 129:49-58
    ..It was concluded that proper selection of rate-controlling polymers with release rate modifier excipients will determine overall release profile, duration and mechanism from directly compressed matrices...
  2. Release profile comparison and stability of diltiazem-resin microcapsules in sustained release suspensions
    Varaporn Buraphacheep Junyaprasert
    Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 447 Sri Ayutthaya Road, Bangkok 10400, Thailand
    Int J Pharm 352:81-91
    ..In addition, all sustained release suspensions possessed good stability with low drug leaching and their release profiles were unchanged when compared with the dried microcapsules for 120 days at 30 and 45 degrees C...
  3. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation
    T Nabais
    Faculty of Pharmacy, University of Montreal, Montreal, Que, Canada
    Eur J Pharm Biopharm 65:371-8
    ..In vivo studies demonstrate extended drug absorption, showing that the matrix tablets do not disintegrate immediately. Nevertheless, acetaminophen does not seem to be the most appropriate drug for this type of formulation...
  4. Formulation of controlled-release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation
    Hamdy Abdelkader
    Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, Egypt
    AAPS PharmSciTech 8:E100
    ....
  5. Floating osmotic drug delivery system of ranitidine hydrochloride: development and evaluation--a technical note
    Pramod Kumar
    Department of Pharmaceutics, Institute of Technology, Banaras Hindu University, Varanasi 221005, U.P, India
    AAPS PharmSciTech 9:480-5
  6. Design and study of lamivudine oral controlled release tablets
    Punna Rao Ravi
    Pharmacy Group, Faculty Division III, Birla Institute of Technology and Science, Pilani, Rajasthan, India
    AAPS PharmSciTech 8:E101
    ..The developed controlled release matrix tablets of lamivudine, with good initial release (20%-25% in first hour) and extension of release up to 16 to 20 hours, can overcome the disadvantages of conventional tablets of lamivudine...
  7. Sustained-release tablets of indomethacin-loaded microcapsules: preparation, in vitro and in vivo characterization
    Bin Lu
    West China School of Pharmacy, Sichuan University, Chengdu 610041, China
    Int J Pharm 333:87-94
    ..Pharmacokinetic study in rabbits showed that t(max) was delayed and C(max) lowered compared with tablets C and the values of AUC(0-24 h) of the three tablets were very close...
  8. Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets
    Eddy Castellanos Gil
    Center of Pharmaceutical Chemistry, Calle 200, esq 21, Atabey, Playa, Havana, Cuba
    AAPS PharmSciTech 8:E115
    ..63% vol/vol of native dextran B110-1-2 plus initial porosity in the LBD-dextran matrices with a relative polymer/drug particle size of 4.17 were attributed to the existence of an excipient percolation threshold...
  9. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone
    Ian J Hardy
    Pharmaceutical Research and Development, Merck Sharp and Dohme Ltd, Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom
    Int J Pharm 337:246-53
    ..A validated mathematical model is also presented which allows drug release profiles to be reliably predicted based on the initial HPMC and PVP content in the tablet...
  10. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets
    Antonia Miranda
    Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain
    J Pharm Sci 96:2746-56
    ..This relationship is valid for different drugs, excipients and systems (inert or hydrophilic matrix tablets)...
  11. Microenvironmental pH modulation in solid dosage forms
    Sherif I Farag Badawy
    Bristol Myers Squibb Pharmaceutical Research Institute, New Brunswick, New Jersey, USA
    J Pharm Sci 96:948-59
    ..The incorporation of acidic pH modifiers in the controlled release formulation increases the solubility of the basic drug even as the high pH dissolution medium enters into the dosage form hence increasing drug release rate...
  12. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres
    Manju Rawat
    Institute of Pharmacy, Pt Ravishankar Shukla University, Raipur, C G 492010, India
    AAPS PharmSciTech 8:E116
    ..Thus, Eudragit S100 microspheres can be successfully prepared for oral delivery of enzymes with desirable characters in terms of maximum loading and diffusion release pattern...
  13. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release
    Yaxin Lu
    School of Pharmacy 32 mail box, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang 110016, Liaoning Province, PR China
    J Pharm Sci 96:3252-62
    ....
  14. Comparative study of propranolol hydrochloride release from matrix tablets with KollidonSR or hydroxy propyl methyl cellulose
    J Sahoo
    Royal College of Pharmacy and Health Sciences, Andhapasara Road, Berhampur 760002, Orissa, India
    AAPS PharmSciTech 9:577-82
    ..In conclusion, the in vitro release profile and the mathematical models indicate that release of propranolol hydrochloride can be effectively controlled from a single tablet using HPMC K15M or KollidonSR matrix system...
  15. Basic butylated methacrylate copolymer/kappa-carrageenan interpolyelectrolyte complex: preparation, characterization and drug release behaviour
    H J Prado
    Departamento de Química Orgánica, Universidad de Buenos Aires, Buenos Aires, Argentina
    Eur J Pharm Biopharm 70:171-8
    ..These profiles could be controlled by conveniently modifying the proportion of the IPEC in the tablets...
  16. A novel in situ forming drug delivery system for controlled parenteral drug delivery
    H Kranz
    College of Pharmacy, Freie Universität Berlin, Kelchstr 31, 12169 Berlin, Germany
    Int J Pharm 332:107-14
    ..Therefore, the ISM systems are an attractive alternative to existing complicated microencapsulation methods...
  17. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics
    Evangelos Karavas
    Pharmathen S.A, Pharmaceutical Industry, Pallini Attikis, Attiki, Greece
    Eur J Pharm Biopharm 64:115-26
    ..028 C1.5, where C is the concentration of HPMC in the blend...
  18. Formulation of controlled-release baclofen matrix tablets. II. Influence of some hydrophobic excipients on the release rate and in vitro evaluation
    Hamdy Abdelkader
    Department of Pharmaceutics, Minia University, Minia, Egypt
    AAPS PharmSciTech 9:675-83
    ..The release kinetics was found to be governed by the type and content of the excipients (polymer or filler). The prepared tablets showed no significant change in drug release rate when stored at ambient room conditions for 6 months...
  19. Biodegradable elastomeric scaffolds with basic fibroblast growth factor release
    Jianjun Guan
    McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15219, USA
    J Control Release 120:70-8
    ..The bFGF-releasing PEUU scaffolds thus exhibited a combination of mechanical properties and bioactivity that might be attractive for use in cardiovascular and other soft tissue applications...
  20. A novel system for three-pulse drug release based on "tablets in capsule" device
    Bin Li
    Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210038, PR China
    Int J Pharm 352:159-64
    ..However, lactose favored it. The results reveal that programmed drug delivery to achieve pulsatile drug release for three times daily can be obtained from these tablets in capsule system by systemic formulation approach...
  21. Preparation of a matrix type multiple-unit gastro retentive floating drug delivery system for captopril based on gas formation technique: in vitro evaluation
    Lingam Meka
    Novel Drug Delivery Systems Laboratory, University College of Pharmaceutical Sciences, Kakatiya University, Warangal 506009, Andhra Pradesh, India
    AAPS PharmSciTech 9:612-9
    ..The analysis of the parameter dissolution data after storage at 40 degrees C and 75% RH for 3 months showed, no significant change indicating the two dissolution profiles were considered to be similar (f2 value is more than 50)...
  22. Roller compaction, granulation and capsule product dissolution of drug formulations containing a lactose or mannitol filler, starch, and talc
    Chialu Kevin Chang
    Pfizer Global Research and Development, Pfizer Inc, Ann Arbor, Michigan 48105, USA
    AAPS PharmSciTech 9:597-604
    ....
  23. Mechanisms controlling protein release from lipidic implants: effects of PEG addition
    Sandra Herrmann
    Department of Pharmacy, Ludwig Maximilians University Munich, Butenandtstrasse 5, 81377 Munich, Germany
    J Control Release 118:161-8
    ..Thus, different mass transport mechanisms govern the release of the drug, co-lyophilisation agent and release modifier out of the lipidic implants...
  24. Controlling of systemic absorption of gliclazide through incorporation into alginate beads
    Raida S Al Kassas
    Department of Pharmaceutics, College of Pharmacy, King Saud University, P O Box 17221, Riyadh 11484, Saudi Arabia
    Int J Pharm 341:230-7
    ..The results clearly demonstrated the ability of the system to maintain tight blood glucose level and improved the patient compliance by enhancing, controlling and prolonging the systemic absorption of gliclazide...
  25. Long acting porous microparticle for pulmonary protein delivery
    Min Jung Kwon
    Pharmaceutical and Health Research Institute, Amore Pacific Corporation R and D Center, 314 1, Bora dong, Giheung gu, Yongin si, Gyeonggi Do 446 729, Republic of Korea
    Int J Pharm 333:5-9
    ..In addition, it is expected that these particles arrive at a deep lung epithelium due to low density (high porosity) and limit macrophage recognition because of big particle size (more than 5 microm)...
  26. Preparation and characterization of solid lipid nanoparticles loaded with total flavones of Hippophae rhamnoides (TFH)
    Dongkai Wang
    Shenyang Pharmaceutical University, Shengyang, Liaoning, China
    PDA J Pharm Sci Technol 61:110-20
    ..The advantages of TFH SLNs are the improved oral bioavailability of TFH and the prolonged mean retention time and drug release time...
  27. Effect of preparation conditions on the nutrient release properties of alginate-whey protein granular microspheres
    Lingyun Chen
    Institut de recherche sur les nutraceutiques et les aliments fonctionnels INAF STELA, Université Laval, Sainte Foy, Canada
    Eur J Pharm Biopharm 65:354-62
    ..By careful process design, granular microspheres with potential as oral delivery vehicles for bioactive compounds may be developed...
  28. Practical considerations in development of solid dosage forms that contain cyclodextrin
    Lee A Miller
    Pfizer, Inc, Ann Arbor, Michigan 48105, USA
    J Pharm Sci 96:1691-707
    ....
  29. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles
    B Sarmento
    Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Porto, Porto, Portugal
    Eur J Pharm Biopharm 65:10-7
    ..The presented nanoparticulate system is a promising carrier for insulin oral delivery since it preserves insulin structure and therefore also, potentially, its bioactivity...
  30. N-phthaloylchitosan-g-mPEG design for all-trans retinoic acid-loaded polymeric micelles
    Praneet Opanasopit
    Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand
    Eur J Pharm Sci 30:424-31
    ..When compared to the unprotected ATRA, ATRA loaded in PLC-g-mPEG micelles was efficiently protected from photodegradation. This result suggested that loading of ATRA in micelles improved the chemical stability of ATRA...
  31. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets
    Sandra U Schilling
    Drug Dynamics Institute, College of Pharmacy, University of Texas at Austin, Austin, TX 78712, USA
    Int J Pharm 361:158-68
    ..In summary, CA MH promoted the miscibility between the drug and Eudragit RS PO during hot-melt extrusion, resulting in the extrusion of an amorphous system with improved dissolution characteristics...
  32. Theophylline granule formulation prepared by the wet granulation method: comparison of in vitro dissolution profiles and estimation of in vivo plasma concentrations
    E Karasulu
    Department of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, University of Ege, Bornova, Izmir, Turkey
    Eur J Drug Metab Pharmacokinet 31:291-8
    ..This study indicates that the dosage forms with similar in vitro dissolution profiles may have a similar in vivo performance, and that this performance could be estimated using appropriate correlation equations...
  33. Effect of formulation composition on the properties of controlled release tablets prepared by roller compaction
    Madhusudan Hariharan
    Pfizer Global R and D, Pharmaceutical Sciences, Skokie, Illinois, USA
    Drug Dev Ind Pharm 30:565-72
    ..These simple statistical tools can allow a formulator to rationally select levels of various components in a formulation, improve the quality of products, and develop more robust processes...
  34. Development of a robust once-a-day glipizide matrix system
    Shahla Jamzad
    School of Pharmacy, Temple University, Philadelphia, PA 19140, USA
    J Pharm Pharmacol 59:769-75
    ..Results indicate that the release is reproducible and the system has potential for successful scale-up operation, while complying with recommended Food and Drug Administration guidelines "Scale Up and Post Approval Changes"...
  35. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies
    Tommasina Coviello
    Department of Chemistry and Technology of Biologically Active Compounds, University of Rome La Sapienza, Rome, Italy
    Eur J Pharm Biopharm 66:200-9
    ..Good agreement was found between the simulated and the experimental data...
  36. Gastric floating matrix tablets: design and optimization using combination of polymers
    Shailesh T Prajapati
    Department of Pharmaceutics, Shri Sarvajanik Pharmacy College, Mehsana 384001, Gujarat, India
    Acta Pharm 58:221-9
    ..The quadratic mathematical model developed could be used to predict formulations with desired release and floating properties...
  37. Process analytical technology: chemometric analysis of Raman and near infra-red spectroscopic data for predicting physical properties of extended release matrix tablets
    Rakhi B Shah
    Division of Product Quality Research, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
    J Pharm Sci 96:1356-65
    ..Chemical imaging utilizing NIR detector also demonstrated to show physical changes due to compression differences. In conclusion, sensor technologies can be potentially used to predict physical parameters of the matrix tablets...
  38. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles
    C B Packhaeuser
    Department of Pharmaceutics and Biopharmacy, Philipps Universität, D 35037 Marburg, Ketzerbach 63, 35032 Marburg, Germany
    J Control Release 123:131-40
    ....
  39. A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets
    Shawn A Mitchell
    Water Soluble Polymers, The Dow Chemical Company, Midland, Michigan 48674, USA
    J Pharm Sci 97:2277-85
    ..These predictions need to be validated experimentally...
  40. Polymer mobilization and drug release during tablet swelling. A 1H NMR and NMR microimaging study
    Carina Dahlberg
    YKI, Institute for Surface Chemistry, Stockholm, Sweden
    J Control Release 122:199-205
    ....
  41. Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets
    Hongtao Li
    Faculty of Pharmacy, University of Manitoba, 50 Sifton Road, Winnipeg, MB R3T2N2, Canada
    AAPS PharmSciTech 9:437-43
    ..The developed methodology would be beneficial to formulation scientists in dosage form design and optimization...
  42. Analysis and modeling of swelling and erosion behavior for pure HPMC tablet
    Serafina Chirico
    Department of Chemical and Food Engineering, University of Salerno, Fisciano SA, Italy
    J Control Release 122:181-8
    ..Even if the model was already used in literature, the novelty of our approach is to compare model predictions with a complete set of experimental data, confirming that the main phenomena were correctly identified and described...
  43. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization
    Jie Liu
    Key Laboratory of Drug Targeting, Ministry of Education, Sichuan University, No 17, Section 3, Southern Renmin Road, Chengdu, Sichuan 610041, PR China
    Int J Pharm 340:153-62
    ..In conclusion, SLNs with small particle size, excellent physical stability, high entrapment efficiency, good loading capacity for protein drug can be produced by this novel reverse micelle-double emulsion method in present study...
  44. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles
    Waree Tiyaboonchai
    Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Naresuan University, Pitsanulok 65000, Thailand
    Int J Pharm 337:299-306
    ..The results revealed that after storage in the absence of sunlight for 6 months, the percentages of the remaining curcumin, bisdemethoxycurcumin and demethoxycurcumin were 91, 96 and 88, respectively...
  45. Design and optimization of NSAID loaded nanoparticles
    Swati Sashmal
    Ranbaxy Research Lab, Guargaon, India
    Pak J Pharm Sci 20:157-62
    ..The study collaborates on the feasibility and suitability of aqueous polymeric drug delivery system, employing statistical design to develop a clinically useful Nanoparticle system with targeting potential...
  46. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles
    K Vivek
    Drug Delivery Research Laboratory, Center of Relevance and Excellence in NDDS, Pharmacy Department, GH Patel Building, Donor s Plaza, Fatehgunj, M S University, Baroda 390002, Gujarat, India
    AAPS PharmSciTech 8:E83
    ..A significant increase in size and zeta potential was observed for GTS SLN and WE 85 SLN dispersions stored at 40 degrees C. Release of OL from the SLNs was sustained up to 48 hours in pH 7.4 PB and obeyed Higuchi's release kinetics...
  47. Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin
    Weiling He
    University of Wyoming School of Pharmacy, Laramie, Wyoming 82071, USA
    J Pharm Sci 97:2250-9
    ..The oral bioavailability of Tp5 could be enhanced by PBCA nanoparticles. PBCA-Tp5-NP had the property of sustained-release and the efficacy of Tp5 was not changed after formulation...
  48. Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres
    J L Arias
    Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada, Spain
    Int J Pharm 337:282-90
    ....
  49. Development and evaluation of a gastroretentive drug delivery system for the low-absorption-window drug celecoxib
    Javed Ali
    Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, Hamdard Nagar, New Delhi, India
    PDA J Pharm Sci Technol 61:88-96
    ..The correlation coefficient (R2 value) was obtained upon fitting the data to Higuchi equation, which signifies that the mechanism of release of celecoxib from the microspheres was diffusion rate-limited...
  50. Formulation of spray-dried phenytoin loaded poly(epsilon-caprolactone) microcarrier intended for brain delivery to treat epilepsy
    Zhuzhu Li
    Division of Pharmaceutical Sciences, University of Missouri Kansas City, 5005 Rockhill Road, Kansas City, Missouri 64110 2499, USA
    J Pharm Sci 96:1018-30
    ..These data suggested that PHT containing spray-dried PCL-microcarrier may be a promising drug delivery system for local brain delivery and long-term treatment of pharmacoresistant epilepsy...
  51. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs
    Mahesh D Chavanpatil
    Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA
    J Pharm Sci 96:3379-89
    ..In conclusion, we have formulated a novel surfactant-polymer drug delivery carrier demonstrating sustained release of water-soluble drugs...
  52. Control of burst release from nanogels via layer by layer assembly
    Jeremy P K Tan
    School of Mechanical and Aerospace Engineering, Nanyang Technological University, 50, Nanyang Avenue, Singapore 639798, Singapore
    J Control Release 128:248-54
    ..An empirical relationship describing the number of polyelectrolyte layers and time to attain steady-state drug concentration (tau(D)) was developed, where tau(D) increased with increasing polyelectrolyte layers...
  53. Preparation of acetazolamide composite microparticles by supercritical anti-solvent techniques
    Ana Rita C Duarte
    Nutraceuticals and Delivery Laboratory, ITQB IBET, Aptd 12, 2781 901 Oeiras, Portugal
    Int J Pharm 332:132-9
    ....
  54. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory
    N S Berchane
    Department of Mechanical Engineering, Texas A and M University, College Station, TX, USA
    Int J Pharm 337:118-26
    ..The validated mathematical model can be used to predict small-molecule drug release from PLG microsphere populations...
  55. Differential scanning calorimetry and surface morphology studies on coated pellets using aqueous dispersions
    Yuen K H
    Department of Pharmacy, Islamia University Bahawalpur, Pakistan
    Pak J Pharm Sci 18:19-23
    ..The polymer surface of coated pellets after 12 hours dissolution testing seemed to be shrunk and size of the pellets were also reduced indicating the depletion of reservoir layer...
  56. The use of agar as a novel filler for monolithic matrices produced using hot melt extrusion
    John G Lyons
    Centre for Biopolymer and Biomolecular Research, Athlone Institute of Technology, Westmeath, Ireland
    Eur J Pharm Biopharm 64:75-81
    ..The results detailed within this paper indicate that agar is a viable filler for extended release hot melt produced dosage forms...
  57. Crystal growth formation in melt extrudates
    Caroline Bruce
    College of Pharmacy, The University of Texas, Austin, TX 78712, United States
    Int J Pharm 341:162-72
    ..In vitro drug release studies showed no significant change during storage for up to 6 months at 25 degrees C/60% relative humidity and 40 degrees C/75% relative humidity...
  58. Stable carbamazepine colloidal systems using the cosolvent technique
    D Douroumis
    Department of Pharmaceutical Technology, University of Jena, Lessingstrasse 8, D 07743 Jena, Germany
    Eur J Pharm Sci 30:367-74
    ..Suspension stability was evaluated over 5 months where the particle size remained constant. FT-Raman studies showed the existence of form I within the stable CBZ suspensions...
  59. In vitro release of a water-soluble agent from low viscosity biodegradable, injectable oligomers
    Soroor Sharifpoor
    Department of Chemical Engineering, Queen s University, Kingston, Canada
    Eur J Pharm Biopharm 65:336-45
    ..The results are consistent with an osmotically driven release mechanism...